RE:CONSOLIDATION/DILUTIONJR you have to understand that unitl the biogen approval it was positioned like once aducanumab is approved then there is a line up for partnership and investment banks are wiling to fund us. Didn't sound like they were going to dilute by issuing another 150 MN shares at discount, if that didn't happen.. we should be at 50 cents .. but we need cash too. The stock is like capped at 18 cents , people are forced to cash out when even for long term holders, something like Nasdaq index would have done better. So far there is only risk , no reward yet. I am for the nasdaq move and I never used to bash the management about the pay etc but what they do now needs to be dealt with lawyers. I just can't afford one at this stage . Thanks pmn